Skip to main content

Published locations for Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 results

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 results

User login

  • Reset your password
  • /content/atezolizumab-tnbc-indication-jeopardy-because-phase-3-results
  • /oncologypractice/article/228195/breast-cancer/atezolizumab-tnbc-indication-jeopardy-because-phase-3
  • /jcomjournal/article/228195/breast-cancer/atezolizumab-tnbc-indication-jeopardy-because-phase-3
  • /hematology-oncology/article/228195/breast-cancer/atezolizumab-tnbc-indication-jeopardy-because-phase
  • /advanced-and-metastatic-breast-cancer/article/228195/breast-cancer/atezolizumab-tnbc-indication
  • /breast-cancer-icymi/article/228195/breast-cancer/atezolizumab-tnbc-indication-jeopardy-because-phase